Maven Securities’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,688
| Closed | -$944K | – | 298 |
|
|
2024
Q4 | $944K | Sell |
16,688
-51,168
| -75% | -$2.89M | 0.02% | 118 |
|
|
2024
Q3 | $46.8K | Hold |
67,856
| – | – | ﹤0.01% | 285 |
|
|
2024
Q2 | $46.8K | Hold |
67,856
| – | – | ﹤0.01% | 271 |
|
|
2024
Q1 | $46.8K | Buy |
+67,856
| New | +$46.8K | ﹤0.01% | 297 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 316 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 289 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 248 |
|
|
2022
Q4 | – | Sell |
-25,756
| Closed | -$1.83M | – | 259 |
|
|
2022
Q3 | $1.83M | Buy |
+25,756
| New | +$1.83M | 0.03% | 107 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 354 |
|
|
2022
Q1 | – | Sell |
-4,917
| Closed | -$307K | – | 377 |
|
|
2021
Q4 | $307K | Buy |
4,917
+2,773
| +129% | +$173K | 0.01% | 269 |
|
|
2021
Q3 | $127K | Sell |
2,144
-5,856
| -73% | -$347K | ﹤0.01% | 448 |
|
|
2021
Q2 | $535K | Buy |
+8,000
| New | +$535K | 0.02% | 315 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 819 |
|